#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3080	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2129	261.3	0	.	n	.	0	C1450T	SNP	1450	1450	C	1652	1652	T	331	T	202	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	3080	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2129	261.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1386	1386	C	350	C	214	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5898	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3425	301.0	0	.	n	.	0	T695C	SNP	695	695	T	1004	1004	C	428	C	255	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5898	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3425	301.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1646	1646	A	276	A	178	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5898	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3425	301.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	1947	1947	G	280	G	176	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5898	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3425	301.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2280	2280	C	340	C	209	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5898	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3425	301.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2906	2906	T	323	T,C,G	149,47,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5898	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3425	301.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2354	2354	A	320	A	198	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5898	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3425	301.0	0	HET	.	.	.	C933T	.	933	933	C	1242	1242	C	306	C,T	143,45	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	242	folP	855	855	100.0	folP.l15.c4.ctg.1	1407	31.2	1	SNP	p	R229S	1	.	.	685	687	AGC	899	901	AGC	43;43;40	A;G;C	26;26;25	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	531	564	gyrA	2751	2724	99.67	gyrA.l15.c30.ctg.1	2724	34.1	0	.	p	.	0	L770F	NONSYN	2308	2310	TTG	2304	2306	TTT	9;9;9	T;T;T,G	4;5;0,4	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	531	564	gyrA	2751	2724	99.67	gyrA.l15.c30.ctg.1	2724	34.1	0	.	p	.	0	G779R	NONSYN	2335	2337	GGC	2331	2333	CGC	8;9;9	C,G;G;C	0,5;5;5	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	531	564	gyrA	2751	2724	99.67	gyrA.l15.c30.ctg.1	2724	34.1	0	.	p	.	0	I781N	NONSYN	2341	2343	ATC	2337	2339	AAC	9;9;9	A;A,T;C	4;0,5;6	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	531	564	gyrA	2751	2724	99.67	gyrA.l15.c30.ctg.1	2724	34.1	0	.	p	.	0	S783R	NONSYN	2347	2349	AGC	2343	2345	CGC	9;9;10	C,A;G,A;C	1,5;5,1;7	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	531	564	gyrA	2751	2724	99.67	gyrA.l15.c30.ctg.1	2724	34.1	1	SNP	p	S91F	1	.	.	271	273	TTC	267	269	TTC	38;39;39	T;T;C	25;25;25	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	531	564	gyrA	2751	2724	99.67	gyrA.l15.c30.ctg.1	2724	34.1	1	SNP	p	D95G	1	.	.	283	285	GGC	279	281	GGC	47;47;47	G;G;C	29;29;29	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	531	564	gyrA	2751	2724	99.67	gyrA.l15.c30.ctg.1	2724	34.1	1	SNP	p	G95N	0	.	.	283	285	GGC	279	281	GGC	47;47;47	G;G;C	29;29;29	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	164	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1234	25.0	1	SNP	p	G45D	0	.	.	133	135	GGC	471	473	GGC	46;48;48	G;G;C	28;29;30	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	134	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1048	24.2	0	.	n	.	0	A197.	DEL	197	197	A	680	680	A	47	A	35	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	480	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	31.5	1	SNP	p	D86N	0	.	.	256	258	GAC	413	415	GAC	41;41;43	G;A,G;C	26;25,1;27	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	480	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	31.5	1	SNP	p	R87W	0	.	.	259	261	CGT	416	418	CGT	43;43;46	C;G;T	27;26;28	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	480	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	31.5	1	SNP	p	R87I	0	.	.	259	261	CGT	416	418	CGT	43;43;46	C;G;T	27;26;28	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	480	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	31.5	1	SNP	p	S87R	1	.	.	259	261	CGT	416	418	CGT	43;43;46	C;G;T	27;26;28	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	480	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	31.5	1	SNP	p	S88P	0	.	.	262	264	TCC	419	421	TCC	45;45;45	T;C;C	28;27;27	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	542	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2484	38.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1517	1519	GGC	35;36;36	G;G;C	23;23;25	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1181	1183	GCA	74;74;74	G;C;A,C	45;43;44,1	penA.41.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1184	1186	ATC	76;76;76	A;T;C,G	46;45;44,1	penA.41.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1196	1198	GTG	72;76;76	G;T;G	44;43;46	penA.41.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1196	1198	GTG	72;76;76	G;T;G	44;43;46	penA.41.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1700	1702	ACC	41;40;40	A;C;C	25;27;25	penA.41.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1754	1756	GCG	39;39;39	G;C;G	26;25;27	penA.41.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1754	1756	GCG	39;39;39	G;C;G	26;25;27	penA.41.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1877	1879	AGC	38;38;40	A;G;C	25;25;25	penA.41.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1886	1888	GGC	39;39;36	G;G;C	26;26;22	penA.41.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.41.001	penA.41.001	1	1	27	568	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2296	42.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1904	1906	CCG	32;31;31	C;C;G	19;19;19	penA.41.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	888	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	2661	55.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1393	1395	CCG	23;23;23	C;C;G	16;15;15	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	266	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1858	24.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	611	611	C	19	C	12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	256	258	AAT	5;5;4	A;A;T	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	259	261	AAT	4;4;4	A;A;T	2;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	283	285	GCA	3;3;3	G;C;A	2;1;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	306	308	GTA	3;3;3	G;T;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	S236N	NONSYN	706	708	AGC	312	314	AAC	2;2;2	A;A;C	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	.	MULTIPLE	709	711	AAC	316	321	TGGCAT	2;2;2;2;2;2	T;G;G;C;A;T	2;2;2;2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	D238A	NONSYN	712	714	GAT	322	324	GCT	2;2;1	G;C;T	2;2;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	382	384	TTA	1;1;1	T;T;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	427	429	CAT	1;1;1	C;A;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	D274G	NONSYN	820	822	GAT	430	432	GGT	1;1;1	G;G;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	30	porB1a	984	297	90.7	porB1a.l6.c4.ctg.1	530	3.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	439	441	TAC	1;1;1	T;A;C	1;1;1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	0	.	p	.	0	N38E	NONSYN	112	114	AAT	332	334	GAA	57;55;55	G;A;A	38;34;34	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	581	583	AAC	49;49;49	A;A;C	32;31;31	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	0	.	p	.	0	N134D	NONSYN	400	402	AAT	620	622	GAT	37;38;38	G;A,T;T	21;24,1;22	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	0	.	p	.	0	P175S	NONSYN	523	525	CCA	743	745	TCA	54;54;54	T;C;A	32;34;34	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	0	.	p	.	0	A218I	NONSYN	652	654	GCC	872	874	ATC	64;64;63	A;T;C	40;39;40	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	0	.	p	.	0	R258H	NONSYN	772	774	CGT	992	994	CAT	41;40;40	C;A;T	26;26;25	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	0	.	p	.	0	S295G	NONSYN	883	885	AGT	1103	1105	GGT	43;49;49	G;G;T	28;31;32	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1202	1204	GCA	51;53;51	G;C;A	35;36;35	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	340	porB1b	1047	1047	98.95	porB1b.l15.c4.ctg.1	1650	38.3	1	SNP	p	G120K	1	.	.	358	360	AAG	578	580	AAG	49;49;49	A;A;G	32;30;30	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1584	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4630	62.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	158	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1002	30.3	1	SNP	p	V57M	1	.	.	169	171	ATG	455	457	ATG	45;44;47	A;T;G	27;26;27	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
